Other
Lower body negative pressure (LBNP)
Lower body negative pressure (LBNP) is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
50%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (66.7%)
N/A1 (33.3%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Evaluation of the ORTHO-LBNP System
NCT03354234
completedphase_4
Methoxyflurane and Fentanyl in LBNP
NCT04641949
completedphase_4
Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
NCT01734096
completed
Detection of Hypovolemia Using Pleth Variability Index (PVI)
NCT01456559
Clinical Trials (4)
Showing 4 of 4 trials
NCT03354234Not Applicable
Evaluation of the ORTHO-LBNP System
NCT04641949Phase 4
Methoxyflurane and Fentanyl in LBNP
NCT01734096Phase 4
Renal Response to Lower Body Negative Pressure in Pre-hypertensive States
NCT01456559
Detection of Hypovolemia Using Pleth Variability Index (PVI)
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4